High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV

Journal of Medical Virology

Volumn 85, Issue 6, 2013, Pages 959-963

  Katsounas, Antonios ^a   Hubbard, Jonathan J ^b   Wang, Crystal H ^b   Zhang, Xiaozhen ^b   Dou, Diana ^b   Shivakumar, Bhavana ^b   Winter, Sophie ^a   Schlaak, Joerg F ^a   Lempicki, Richard A ^c   Masur, Henry ^d   Polis, Michael ^b   Kottilil, Shyam ^b   Osinusi, Anu ^b,c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

HCV; HIV; Interferon response; ISG; ISG 15

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ARTICLE; CLINICAL TRIAL; GENE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON STIMULATED GENE 15; MIXED INFECTION; PROGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS RESISTANCE;

ADULT; ANTIVIRAL AGENTS; COINFECTION; CYTOKINES; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RNA, VIRAL; TREATMENT OUTCOME; UBIQUITINS;

HEPATITIS C VIRUS;

EID: 84876358968     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23576     Document Type: Article

References (12)

1. Binder M, Kochs G, Bartenschlager R, Lohmann V. 2007. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46: 1365-1374.
2. Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, Gerken G, Schlaak JF. 2010. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59: 1111-1119.
3. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM, McGilvray ID. 2005. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444.
4. Chen L, Borozan I, Sun J, Guindi M, Fischer S, Feld J, Anand N, Heathcote J, Edwards AM, McGilvray ID. 2010. Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection. Gastroenterology 138: 1123-1133.
5. Chua PK, McCown MF, Rajyaguru S, Kular S, Varma R, Symons J, Chiu SS, Cammack N, Najera I. 2009. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15. J Gen Virol 90: 2929-2939.
6. Gale M, Jr., Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
7. Kim MJ, Yoo JY. 2010. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J Immunol 185: 4311-4318.
8. Kottilil S, Yan MY, Reitano KN, Zhang X, Lempicki R, Roby G, Daucher M, Yang J, Cortez KJ, Ghany M, Polis MA, Fauci AS. 2009. Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells. Hepatology 50: 34-45.
9. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWt. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 104: 1371-1376.
10. Pawlotsky JM. 2011. The results of phase III clinical trial with telaprevir and boceprevir presented at the liver meeting 2010: A new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending. Gastroenterology 140: 746-754.
11. Sadler AJ, Williams BR. 2011. Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
12. Singal AK, Anand BS. 2009. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 15: 3713-3724.